38 Results for "

Glycemic control

" in MedChemExpress (MCE) Product Catalog:
Products (38)

38 Results for "Glycemic control" in MCE Product Catalog:

Cat. No.: HY-111353
CAS No.: 1234844-11-1
Purity:  99.07%
Research Areas:  

Metabolic Disease

GPR120 Agonist 2 (example 206) is a GPR120 agonist that can be uesd for the study of type II diabetes and diseases associated with poor glycemic control .
loading...
    loading...
Cat. No.: HY-N9911
CAS No.: 492-93-3
1,5-Anhydro-D-mannitol is the analogue of 1,5-Anhydrosorbitol (HY-113075), and can be used as an experimental control. 1,5-Anhydrosorbitol is a short-term marker for glycemic control.
loading...
    loading...
Cat. No.: HY-W768181
CAS No.: 2751790-80-2
Synonyms: 1,5-Anhydro-D-glucitol-13C6
1,5-Anhydrosorbitol- 13C6 (1,5-Anhydro-D-glucitol- 13C6) is the 13C-labeled 1,5-Anhydrosorbitol (HY-113075). 1,5-Anhydrosorbitol is a short-term marker for glycemic control.
loading...
    loading...
Cat. No.: HY-P11044
Research Areas:  

Metabolic Disease

GEP12 is a GLP-1R/Y1-R/Y2-R tri-receptor agonist peptide with an EC50 of 17.3 nM and an IC50 of 19.2 nM for receptor binding. GEP12 may promote glycemic control and weight loss .
loading...
    loading...
Cat. No.: HY-112668B
CAS No.: 1174038-86-8
Synonyms: SP2086 hydrochloride
Research Areas:  

Others

Retagliptin (SP2086) hydrochloride is a potent inhibitor of beta-amino acids and dipeptidyl peptidase-4 (DPP-4). Retagliptin (SP2086) hydrochloride inhibits type 2 diabetes and improves glycemic control by prolonging the action of intestinal hormones such as glucagon-like peptide-1 (GLP-1) .
loading...
    loading...
Cat. No.: HY-162513
CAS No.: 1123219-12-4
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

DPP-4-IN-10 (compound 1) is a DPP-4 inhibitor. DPP-4-IN-10 is orally active. DPP-4-IN-10 blocks the degradation of GLP-1 and GIP, which may improve glycemic control in type 2 diabetes (T2MD) .
loading...
    loading...
Cat. No.: HY-15408R
CAS No.: 865759-25-7
Synonyms: SYR-472 (Standard)
Trelagliptin (Standard) is the analytical standard of Trelagliptin. This product is intended for research and analytical applications. Trelagliptin (SYR-472) is a potent, orally active and highly selective DPP-4 inhibitor with an IC50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
Cat. No.: HY-125156
CAS No.: 1351438-75-9
Purity:  ≥99.0%
Synonyms: BMS-801576
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

Dapagliflozin-3-O-β-D-glucuronide (BMS-801576) is the metabolite of Dapagliflozin (HY-10450), and is formed in the liver and kidney by uridine diphosphate glucuronosyltransferase-1A9 (UGT1A9). Dapagliflozin is a selective inhibitor for SGLT2, that can be used to improve glycemic control and attenuate type 2 diabetes .
loading...
    loading...
Cat. No.: HY-15408AR
CAS No.: 1029877-94-8
Synonyms: SYR-472 succinate (Standard)
Trelagliptin (succinate) (Standard) is the analytical standard of Trelagliptin (succinate). This product is intended for research and analytical applications. Trelagliptin (SYR-472) succinate is a potent, orally active and highly selective DPP-4 inhibitor with an IC50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
Cat. No.: HY-13967A
CAS No.: 865231-45-4
AMG 837 sodium salt is an orally active, selective GPR40/FFA1 agonist with an EC50 of 1.5 nM against human GPR40. AMG 837 sodium salt stimulates insulin secretion in a glucose-dependent manner, and effectively improves glycemic control in both normal and diabetic rodent models . AMG 837 sodium salt binds to the BacA protein and impairs the survival and replication of Brucella. AMG 837 sodium salt can be used in research related to type 2 diabetes and brucellosis .
loading...
    loading...
Cat. No.: HY-111294
CAS No.: 851389-35-0
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

ASP4000 hydrochloride is an orally effective dipeptidyl peptidase 4 (DPP4) inhibitor, with an IC50 value of 2.25 nM against human recombinant DPP4, and exhibits hypoglycemic activity. By inhibiting DPP4 activity, ASP4000 hydrochloride reduces the degradation of active glucagon-like peptide-1 (GLP-1), thereby persistently increasing postprandial active GLP-1 levels and improving glycemic control. ASP4000 hydrochloride can be used in studies related to type 2 diabetes .
loading...
    loading...
Cat. No.: HY-113075R
CAS No.: 154-58-5
Synonyms: 1,5-Anhydro-D-glucitol (Standard)
1,5-Anhydrosorbitol (Standard) is the analytical standard of 1,5-Anhydrosorbitol. This product is intended for research and analytical applications. 1,5-Anhydrosorbitol is a short-term marker for glycemic control.
loading...
    loading...
Cat. No.: HY-105074R
CAS No.: 196808-45-4
Synonyms: GI262570 (Standard); GI262570X (Standard)
Research Areas:  

Metabolic Disease

Farglitazar (Standard) is the analytical standard of Farglitazar (HY-105074). This product is intended for research and analytical applications. Farglitazar is a PPARγ agonist that has significant therapeutic benefits such as glycemic control in type 2 diabetic patients.
loading...
    loading...
Cat. No.: HY-111353R
CAS No.: 1234844-11-1
GPR120 Agonist 2 (Standard) is the analytical standard of GPR120 Agonist 2 (HY-111353). This product is intended for research and analytical applications. GPR120 Agonist 2 (example 206) is a GPR120 agonist that can be uesd for the study of type II diabetes and diseases associated with poor glycemic control .
loading...
    loading...
Cat. No.: HY-189613
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

EOS34295 is a dipeptidyl peptidase-IV (DPP-IV) inhibitor predicted to have oral activity. EOS34295 competitively binds to key residues in the active site of DPP-IV, inhibiting its enzymatic activity and blocking the degradation of incretins such as GLP-1/GIP, ultimately promoting insulin release to improve glycemic control. EOS34295 can be used in the study of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-14341
CAS No.: 528859-61-2
Target:  

5-HT Receptor

Research Areas:  

Metabolic Disease

E-6837 is a selective and orally active 5-HT6 receptor ligand. E-6837 demonstrates partial agonism at a presumably silent rat 5-HT6 receptor and full agonism at a constitutively active human 5-HT6 receptor by monitoring the cAMP signaling pathway. E-6837 induces hypophagia, reduces fat mass and body weight, and improves glycemic control. E-6837 can be used for the research of obesity .
loading...
    loading...
Cat. No.: HY-167075
CAS No.: 851510-67-3
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

ASP4000 free base is an orally effective dipeptidyl peptidase 4 (DPP4) inhibitor, with an IC50 value of 2.25 nM against human recombinant DPP4, and exhibits hypoglycemic activity. By inhibiting DPP4 activity, ASP4000 free base reduces the degradation of active glucagon-like peptide-1 (GLP-1), thereby persistently increasing postprandial active GLP-1 levels and improving glycemic control. ASP4000 free base can be used in studies related to type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P11604
Target:  

Phosphatase

Research Areas:  

Inflammation/Immunology

C16 acid-I-{Lys (C10 diacid)}-KQELRRIGDEF is a cell-permeable and internalizable PTPN1/2 inhibitor, with IC50 values of 107.6 nM and 3375 nM, respectively. C16 acid-I-{Lys (C10 diacid)}-KQELRRIGDEF restores insulin signaling in HepG2 cells. C16 acid-I-{Lys (C10 diacid)}-KQELRRIGDEF achieves glycemic control in db/db diabetic mice. C16 acid-I-{Lys (C10 diacid)}-KQELRRIGDEF can be used in the research of type 2 diabetes .
loading...
    loading...